Company profile

Ticker
HUM
Exchange
Website
CEO
Bruce Dale Broussard
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
610647538

HUM stock data

(
)

Calendar

29 Apr 20
6 Jul 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 18.94B 16.3B 16.24B 16.25B
Net income 473M 512M 689M 940M
Diluted EPS 3.56 3.84 5.14 6.94
Net profit margin 2.50% 3.14% 4.24% 5.79%
Operating income 1.07B 362M 868M 1.12B
Net change in cash 2B -1.47B 749M 901M
Cash on hand 6.05B 4.05B 5.53B 4.78B
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 64.89B 56.91B 53.77B 54.38B
Net income 2.71B 1.68B 2.45B 614M
Diluted EPS 20.1 12.16 16.81 4.07
Net profit margin 4.17% 2.96% 4.55% 1.13%
Operating income 3.19B 3.1B 4.26B 1.74B
Net change in cash 1.71B -1.7B 165M 1.31B
Cash on hand 4.05B 2.34B 4.04B 3.88B

Financial data from Humana earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
1 Jul 20 Susan M Diamond Humana Common Payment of exercise Dispose F No 390.385 97 37.87K 1,908
1 Jul 20 Susan M Diamond Humana Common Option exercise Aquire M No 0 290 0 2,005
1 Jul 20 Susan M Diamond RSU Humana Common Option exercise Dispose M No 0 290 0 582
30 Jun 20 McDonald William J. RSU Humana Common Grant Aquire A No 384.15 78 29.96K 10,328
30 Jun 20 Karen Katz RSU Humana Common Grant Aquire A No 384.15 78 29.96K 164
30 Jun 20 Hilzinger Kurt J RSU Humana Common Grant Aquire A No 384.15 235 90.28K 10,044
29 May 20 Peterson Marissa T Humana Common Sell Dispose S No 399.89 1,246 498.26K 1,229
93.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 772 795 -2.9%
Opened positions 102 149 -31.5%
Closed positions 125 86 +45.3%
Increased positions 240 231 +3.9%
Reduced positions 322 311 +3.5%
13F shares
Current Prev Q Change
Total value 306.74B 368.8B -16.8%
Total shares 122.85M 124.33M -1.2%
Total puts 1.47M 1.69M -12.6%
Total calls 1.4M 1.26M +10.6%
Total put/call ratio 1.1 1.3 -21.0%
Largest owners
Shares Value Change
BLK BlackRock 10.81M $3.39B -10.7%
Vanguard 10.51M $3.3B +3.1%
N Price T Rowe Associates 9.51M $2.99B +399.7%
Capital International Investors 8.35M $2.62B -16.8%
FMR 6.13M $1.92B -1.7%
STT State Street 5.82M $1.83B +0.7%
Capital World Investors 4.81M $1.51B -7.4%
Capital Research Global Investors 3.7M $1.16B -52.7%
Renaissance Technologies 3.53M $1.11B +19.6%
Wellington Management 2.22M $696.58M -9.2%
Largest transactions
Shares Bought/sold Change
N Price T Rowe Associates 9.51M +7.61M +399.7%
Capital Research Global Investors 3.7M -4.12M -52.7%
Capital International Investors 8.35M -1.69M -16.8%
Norges Bank 0 -1.3M EXIT
BLK BlackRock 10.81M -1.3M -10.7%
Jennison Associates 1.26M +1.05M +507.7%
Boston Partners 804.3K -733.49K -47.7%
Glenview Capital Management 335.95K -723.84K -68.3%
Lone Pine Capital 2.16M +691.3K +46.9%
Marshall Wace North America 51.17K -635.48K -92.5%

Financial report summary

?
Risks
  • Risks Relating to Our Business
  • If we fail to effectively implement our operational and strategic initiatives, including our Medicare initiatives and our state-based contracts strategy, our business may be materially adversely affected, which is of particular importance given the concentration of our revenues in these products. In addition, there can be no assurances that we will be successful in maintaining or improving our Star ratings in future years.
  • If we fail to properly maintain the integrity of our data, to strategically implement new information systems, or to protect our proprietary rights to our systems, our business may be materially adversely affected.
  • If we are unable to defend our information technology security systems against cybersecurity attacks or prevent other privacy or data security incidents that result in security breaches that disrupt our operations or in the unintended dissemination of sensitive personal information or proprietary or confidential information, we could be exposed to significant regulatory fines or penalties, liability or reputational damage, or experience a material adverse effect on our results of operations, financial position, and cash flows.
  • We are involved in various legal actions and governmental and internal investigations, any of which, if resolved unfavorably to us, could result in substantial monetary damages or changes in our business practices. Increased litigation and negative publicity could increase our cost of doing business.
  • As a government contractor, we are exposed to risks that may materially adversely affect our business or our willingness or ability to participate in government health care programs.
  • Our business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase our cost of doing business and may have a material adverse effect on our results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering our Medicare payment rates and increasing our expenses associated with assessments); our financial position (including our ability to maintain the value of our goodwill); and our cash flows.
  • Any failure by us to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on our results of operations, financial position, and cash flows.
  • If we fail to develop and maintain satisfactory relationships with the providers of care to our members, our business may be adversely affected.
  • Our pharmacy business is highly competitive and subjects us to regulations in addition to those we face with our core health benefits businesses.
  • If we do not continue to earn and retain purchase discounts and volume rebates from pharmaceutical manufacturers at current levels, our gross margins may decline.
  • Our ability to obtain funds from certain of our licensed subsidiaries is restricted by state insurance regulations.
  • Downgrades in our debt ratings, should they occur, may adversely affect our business, results of operations, and financial condition.
  • The securities and credit markets may experience volatility and disruption, which may adversely affect our business.
Management Discussion
  • the ability to enroll in multiple programs. The increase is driven by our improved process for identifying and enrolling members in the appropriate program at the right time, coupled with growth in Special Needs Plans, or SNP, membership.
  • The Health Care Reform Law enacted significant reforms to various aspects of the U.S. health insurance industry. Certain significant provisions of the Health Care Reform Law include, among others, mandated coverage requirements, mandated benefits and guarantee issuance associated with commercial medical insurance, rebates to policyholders based on minimum benefit ratios, adjustments to Medicare Advantage premiums, the establishment of federally facilitated or state-based exchanges coupled with programs designed to spread risk among insurers, and the introduction of plan designs based on set actuarial values. In addition, the Health Care Reform Law established insurance industry assessments, including an annual health insurance industry fee. The annual health insurance industry fee, which was suspended in 2019, but has resumed for calendar year 2020, is not deductible for income tax purposes and significantly increases our effective tax rate. We expect to pay the federal government $1.2 billion in September 2020 for this fee. Under current law, the health industry fee will be permanently repealed beginning in calendar year 2021.
  • It is reasonably possible that the Health Care Reform Law and related regulations, as well as other current or future legislative, judicial or regulatory changes, such as legislative and regulatory changes associated with COVID-19, including restrictions on our ability to manage our provider network or otherwise operate our business, or restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, increases in member benefits or changes to member eligibility criteria without corresponding increases in premium payments to us, or increases in regulation of our prescription drug benefit businesses, in the aggregate may have a material adverse effect on our results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs, further lowering our Medicare payment rates and increasing our expenses associated with assessments); our financial position (including our ability to maintain the value of our goodwill); and our cash flows.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: alternative, assumption, began, burden, carefully, CareSource, charge, China, closure, combat, component, concentration, confidential, Conviva, county, cybersecurity, dealing, degree, deliberate, demand, diagnostic, difficult, discontinued, discontinuing, disease, disrupt, disrupting, dissemination, distancing, drawn, drew, ease, effort, emergence, emergency, Enclara, Enhanced, enterprise, ESRD, expediting, external, face, fiscal, fluidity, Foundation, full, geographic, global, globally, harm, impliedly, Indenture, infection, infrastructure, insufficient, labor, Lastly, leap, lifting, log, magnitude, margin, Mellon, mitigate, monitor, moved, movement, necessarily, nonpayment, nonperformance, NOPAT, outbreak, pandemic, partnership, permanently, persist, phishing, physical, preliminary, Premier, pressure, proactive, proprietary, prove, quickly, rapid, rebasing, recover, referral, reinstatement, relax, relaxation, relief, remote, renal, repeal, repealed, resumption, revert, robust, Rx, Seventeenth, situation, Sixteenth, solution, speed, stage, strain, subset, supply, Supreme, surfaced, telehealth, telephone, testing, therapeutic, Trust, trustee, turn, unauthorized, unobservable, vaccine, variance, waiving, Walmart, widespread, World, Wuhan, York
Removed: amortizable, appeal, area, award, callable, CGIC, closed, closing, collateralized, commencement, commensurate, computer, Continental, Corporation, Curo, defined, depend, depreciable, disposed, earliest, episodically, equipment, escalation, excluded, exercise, exit, exited, expedient, experiencing, expired, extend, Family, flu, FPG, furniture, Goldman, hand, hardware, HMO, holistically, impaired, implicit, incentive, index, invested, Kanawha, KIC, KMG, Lake, lawsuit, lease, leased, leasehold, levied, LLC, located, longer, maintenance, MCCI, meet, merging, Miami, migration, MMA, noncancelable, nonlease, Orange, Orlando, Osceola, practical, prepayable, pretax, prevail, prime, quantitative, reassessing, reconsideration, recoverable, recur, regulator, reinsuring, reissued, renewal, rent, rental, residual, ROU, scheduled, Seminole, shortening, simultaneously, space, statewide, sublease, substance, title, treating, unchanged, unit, variable, voluntary